According to Fars news agency’s health group, Alireza Askari, CEO of the Medical Procurement Organization, said: One of the important and produced products of this company is blood purification filters needed by thalassemia patients.
Stating that the raw materials of this product are imported, the CEO of the Medical Supply Organization added: Lucosite filters were banned in 2017, and the use of raw materials from other companies also caused problems, which will be solved with the arrival of quality raw materials.
Askari pointed out that the raw materials for the production of 100,000 filters are enough for the production of the country for one year, and continued: If needed, a new shipment will enter the country after the request of the Ministry of Health.
Pointing out that the currency of this sector has been removed, he said: The removal of the preferred currency has created problems in providing working capital for units like Sohahalal, and the working capital has increased 6 to 7 times with the removal of currency.
He stated that the production items of Sohahlal Company are covered by insurance companies and no cost is imposed on the patients, and he continued: It is expected that the banks will cooperate in providing working capital and helping to continue the activities of these companies.
The CEO of the Medical Supply Organization, pointing out that in the syringe production sector, 100% of the country’s needs are met with the production of several domestic companies, continued: In this sector, Soha Helal Hamr Company has the ability to export its manufactured products.
end of message/
You can edit this article
Suggest this article for the first page